SplashBIO™ is a new scalable biomarker platform for clinical trials for early biomarker, genetic, and cognitive testing. This innovation uses biomarker tests to accelerate enrollment, save money, and reduce screen failure rates.

Meet with us at AAIC & learn how SplashBIO™ can help find trial-ready patients & improve your trial’s efficiency!